ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
The Tang Prize 2026 recognises three leading scientists in the field of cellular immunotherapy “for the discovery and development of TIL and CAR-T therapies, which have revolutionized treatment for blood cancers and solid tumours.”
imphoenix82
The targeted radioligand therapy Pluvicto will initially be available through selected hospitals and nuclear medicine centres across India under Novartis’ partnership-led access model.
imphoenix82
The NMPA clearance allows Adcentrx to include China-based clinical centres in its ongoing Phase 1a/1b trial evaluating the ADC in patients with late-stage solid tumours, including prostate cancer.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Email Us: support@healthxploreindia.com
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
